ORAP Drug Patent Profile
✉ Email this page to a colleague
When do Orap patents expire, and what generic alternatives are available?
Orap is a drug marketed by Teva, Concordia Pharms Inc, and Advanz Pharma. and is included in three NDAs.
The generic ingredient in ORAP is prednisolone sodium phosphate. There are two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Orap
A generic version of ORAP was approved as prednisolone sodium phosphate by BAUSCH AND LOMB INC on July 29th, 1994.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ORAP?
- What are the global sales for ORAP?
- What is Average Wholesale Price for ORAP?
Summary for ORAP
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Patent Applications: | 7,179 |
| Drug Prices: | Drug price information for ORAP |
| DailyMed Link: | ORAP at DailyMed |
US Patents and Regulatory Information for ORAP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | ORAP | pimozide | TABLET;ORAL | 017473-003 | Aug 27, 1997 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Advanz Pharma | ORAPRED ODT | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 021959-001 | Jun 1, 2006 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | ORAP | pimozide | TABLET;ORAL | 017473-001 | Jul 31, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Concordia Pharms Inc | ORAPRED | prednisolone sodium phosphate | SOLUTION;ORAL | 075117-001 | Dec 14, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Advanz Pharma | ORAPRED ODT | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 021959-003 | Jun 1, 2006 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
